• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血色素沉着症相关突变杂合子对非酒精性脂肪性肝病的易感性增加。

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.

作者信息

Valenti L, Dongiovanni P, Fracanzani A L, Santorelli G, Fatta E, Bertelli C, Taioli E, Fiorelli G, Fargion S

机构信息

Department of Internal Medicine, Ospedale Maggiore IRCCS, University of Milan, Milan, Italy.

出版信息

Dig Liver Dis. 2003 Mar;35(3):172-8. doi: 10.1016/s1590-8658(03)00025-2.

DOI:10.1016/s1590-8658(03)00025-2
PMID:12779071
Abstract

BACKGROUND

Insulin resistance is a key feature of nonalcoholic fatty liver disease. Patients with hereditary hemochromatosis, a disease characterized by progressive iron overload due, in most cases, to homozygosity for C282Y mutation in the HFE gene, have often decreased insulin sensitivity and release.

AIMS

To determine whether increased iron parameters/heterozygosity for the mutations of the HFE gene confer susceptibility to nonalcoholic fatty liver disease.

PATIENTS

One hundred and thirty-four consecutive Italian patients with clinical and ultrasonographic diagnosis of nonalcoholic fatty liver disease (82 with hyperferritinemia), half confirmed by liver biopsy.

METHODS

Insulin was determined by radioimmunoassay. HFE gene mutations were determined by polymerase chain reaction and restriction fragment length polymorphism analysis.

RESULTS

(1) Prevalence of C282Y HFE mutation was significantly higher in patients with nonalcoholic fatty liver disease compared to controls, the difference being more striking in patients with hyperferritinemia than in those without. (2) The presence of mild iron overload was associated with a lower insulin release. (3) Carriers of C282Y mutation developed nonalcoholic fatty liver disease despite lower body mass index and triglycerides.

CONCLUSION

The mild iron overload associated with heterozygosity for C282Y HFE mutation confers susceptibility to nonalcoholic fatty liver disease, causing relative insulin deficiency.

摘要

背景

胰岛素抵抗是非酒精性脂肪性肝病的关键特征。遗传性血色素沉着症患者,这种疾病的特征是在大多数情况下由于HFE基因C282Y突变的纯合性导致铁进行性过载,其胰岛素敏感性和释放常常降低。

目的

确定铁参数增加/HFE基因突变的杂合性是否会增加非酒精性脂肪性肝病的易感性。

患者

134例连续的意大利患者,经临床和超声诊断为非酒精性脂肪性肝病(82例伴有高铁蛋白血症),其中一半经肝活检确诊。

方法

采用放射免疫分析法测定胰岛素。通过聚合酶链反应和限制性片段长度多态性分析确定HFE基因突变。

结果

(1)非酒精性脂肪性肝病患者中C282Y HFE突变的患病率显著高于对照组,高铁蛋白血症患者的差异比无高铁蛋白血症患者更显著。(2)轻度铁过载与较低的胰岛素释放相关。(3)C282Y突变携带者尽管体重指数和甘油三酯较低,但仍患非酒精性脂肪性肝病。

结论

与C282Y HFE突变杂合性相关的轻度铁过载会增加非酒精性脂肪性肝病的易感性,导致相对胰岛素缺乏。

相似文献

1
Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.遗传性血色素沉着症相关突变杂合子对非酒精性脂肪性肝病的易感性增加。
Dig Liver Dis. 2003 Mar;35(3):172-8. doi: 10.1016/s1590-8658(03)00025-2.
2
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.高铁蛋白血症、铁过载和多种代谢改变可识别非酒精性脂肪性肝炎的高危患者。
Am J Gastroenterol. 2001 Aug;96(8):2448-55. doi: 10.1111/j.1572-0241.2001.04052.x.
3
Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.德国遗传性血色素沉着症患者的铁过载、HFE 突变 H63D/C282Y 的基因型表达以及转铁蛋白受体 Hin6I 和 BanI 多态性
Eur J Immunogenet. 2000 Jun;27(3):129-34. doi: 10.1046/j.1365-2370.2000.00215.x.
4
[The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].[韩国非酒精性脂肪性肝病患者外周铁过载的患病率及HFE基因(H63D)突变情况]
Korean J Hepatol. 2007 Jun;13(2):174-84.
5
HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.遗传性血色素沉着症基因突变、肝脏铁含量与肝纤维化:非酒精性脂肪性肝炎与C282Y的种族特异性关联,而非与纤维化严重程度的关联。
Hepatology. 2002 Jul;36(1):142-9. doi: 10.1053/jhep.2002.33892.
6
Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.携带HFE S65C基因突变患者的轻度铁过载:一项针对疑似铁过载患者和健康对照者的回顾性研究
Gut. 2002 Nov;51(5):723-30. doi: 10.1136/gut.51.5.723.
7
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.铁负荷、HFE突变和胰岛素抵抗对非酒精性脂肪肝纤维化的相对贡献。
Hepatology. 2004 Jan;39(1):179-87. doi: 10.1002/hep.20023.
8
Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.巴西非酒精性脂肪性肝炎患者中缺乏铁和HFE基因突变致病作用的证据。
Braz J Med Biol Res. 2003 Jun;36(6):739-45. doi: 10.1590/s0100-879x2003000600009. Epub 2003 Jun 3.
9
Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.非酒精性脂肪性肝炎患者中铁代谢紊乱基因突变的患病率及其与肝纤维化程度的相关性
Arq Gastroenterol. 2006 Jul-Sep;43(3):224-8. doi: 10.1590/s0004-28032006000300013.
10
Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.初次基因检测时 HFE C282Y 杂合子中的铁过载:一种鉴定罕见 HFE 变异体的策略。
Haematologica. 2011 Apr;96(4):507-14. doi: 10.3324/haematol.2010.029751. Epub 2011 Jan 12.

引用本文的文献

1
Integrating systemic inflammation and liver biomarkers: prognostic implications of the ferritin index in heart failure.整合全身炎症和肝脏生物标志物:铁蛋白指数在心力衰竭中的预后意义
Ann Med. 2025 Dec;57(1):2540020. doi: 10.1080/07853890.2025.2540020. Epub 2025 Aug 1.
2
Quantitative assessment of inflammation and evaluation of spatial heterogeneity for non-alcoholic fatty liver disease in mice based on iron-adjustive T1.基于铁校正T1的小鼠非酒精性脂肪性肝病炎症定量评估及空间异质性评价
Quant Imaging Med Surg. 2024 Jan 3;14(1):219-230. doi: 10.21037/qims-23-782. Epub 2023 Oct 29.
3
Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies.
用于非酒精性脂肪性肝病流行病学和临床研究中无创诊断及监测的肝脏脂肪评分
J Clin Transl Hepatol. 2023 Oct 28;11(5):1212-1227. doi: 10.14218/JCTH.2022.00019. Epub 2023 May 31.
4
Secondary Iron Overload and the Liver: A Comprehensive Review.继发性铁过载与肝脏:综述
J Clin Transl Hepatol. 2023 Aug 28;11(4):932-941. doi: 10.14218/JCTH.2022.00420. Epub 2023 Feb 1.
5
Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals.HFE基因变异与瘦人非酒精性脂肪性肝病相关。
JHEP Rep. 2023 Mar 27;5(7):100744. doi: 10.1016/j.jhepr.2023.100744. eCollection 2023 Jul.
6
Consensus Statement on the definition and classification of metabolic hyperferritinaemia.代谢性铁蛋白血症定义和分类的共识声明。
Nat Rev Endocrinol. 2023 May;19(5):299-310. doi: 10.1038/s41574-023-00807-6. Epub 2023 Feb 17.
7
Iron as a therapeutic target in chronic liver disease.铁作为慢性肝病的治疗靶点。
World J Gastroenterol. 2023 Jan 28;29(4):616-655. doi: 10.3748/wjg.v29.i4.616.
8
Dietary iron overload enhances Western diet induced hepatic inflammation and alters lipid metabolism in rats sharing similarity with human DIOS.饮食性铁过载增强了西方饮食诱导的大鼠肝内炎症,并改变了脂质代谢,与人类 DIOS 具有相似性。
Sci Rep. 2022 Dec 10;12(1):21414. doi: 10.1038/s41598-022-25838-3.
9
Serum or plasma ferritin concentration as an index of iron deficiency and overload.血清或血浆铁蛋白浓度作为铁缺乏和铁过载的指标。
Cochrane Database Syst Rev. 2021 May 24;5(5):CD011817. doi: 10.1002/14651858.CD011817.pub2.
10
Iron at the Interface of Hepatocellular Carcinoma.铁在肝细胞癌中的作用。
Int J Mol Sci. 2021 Apr 15;22(8):4097. doi: 10.3390/ijms22084097.